America October 2, 2025
Nanyang Biologics To Go Public in $1.5B SPAC Deal
Singapore-based Nanyang Biologics Pte. Ltd. revealed Thursday it will go public in the U.S. via a merger with special purpose…
America October 2, 2025
Singapore-based Nanyang Biologics Pte. Ltd. revealed Thursday it will go public in the U.S. via a merger with special purpose…
By Rihem Akkouche